When the success of RNA vaccines for Corona was recorded, both by Pfizer and Biontech and by Moderna, the possibility of a world of RNA-based vaccines and drugs opened up. Theoretically, this can be quickly vaccinated against any virus that knows its genetic sequence, as well as vaccinated against certain proteins on top of cancer cells, and cause the body to produce drugs and proteins that it lacks. But the first attempt to expand beyond the vaccine to the corona, so far has not been successful.

By Editor

Leave a Reply